ClinicalTrials.Veeva

Menu

Optical Coherence Tomography Angiography (OCT-A) and Central Serous Chorioretinopathy (CSC) (OPACITY)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Central Serous Chorioretinopathy

Treatments

Device: Optical Coherence Tomography Angiography (OCT-A)

Study type

Observational

Funder types

Other

Identifiers

NCT03950089
OCTA CSC

Details and patient eligibility

About

Optical Coherence Tomography Angiography (OCT-A) is a noninvasive imaging technique that allows one to see blood vessels in the retina. The investigating team used this approach in patients with acute, recurrent and persistent subtypes of Central Serous Chorioretinopathy (CSC) to check for possible Choriocapillaris hypoperfusion. The presence or absence of these microvascular changes was explored in both eyes of the patients and compared to a control group of healthy volunteers. The possibility of a correlation between Choriocapillaris flow deficits, age and spontaneous resolution of serous retinal detachment was also evaluated. This study was conducted in an effort to improve one's understanding of this disease and other pachychoroid disorders.

Enrollment

120 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with acute, recurrent or persistent forms of central serous chorioretinopathy

Exclusion criteria

  • Patients with chronic central serous chorioretinopathy were not eligible for inclusion

Trial design

120 participants in 2 patient groups

Patients with Central Serous Chorioretinopathy
Treatment:
Device: Optical Coherence Tomography Angiography (OCT-A)
Healthy patients
Treatment:
Device: Optical Coherence Tomography Angiography (OCT-A)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems